{"Content: ":"Turkovac[1] (pronunciation: ['tɜ:rkəvæk]) (temporarily named as ERUCOV-VAC[2]) is a COVID-19 vaccine developed by Health Institutes of türkiye and Erciyes University. In November 2020, TURKOVAC started on phase I trials with 44 participants in Turkey.[3] In February 2021, TURKOVAC started on phase II trials with 250 participants in Turkey.[4] In June 2021, TURKOVAC started on phase III trials with 40,800 participants in Turkey.[5] On 25 November 2021, the Turkish Minister of Health reported that Turkovac's application for emergency use authorization had been filed.[6] On 22 December, Turkish President Recep Tayyip Erdogan announced the emergency use approval of Turkovac.[7] This article about COVID-19 vaccines is a stub. You can help Wikipedia by expanding it. This article about vaccines or vaccination is a stub. You can help Wikipedia by expanding it.","Title":"Turkovac - Wikipedia","KeyID":"11123","URL":"https://en.wikipedia.org/wiki/Turkovac"}